Renal Cell Carcinoma
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Aben K, Osanto S, Hulsbergen-van de Kaa C, Soetekouw P, Stemkens D, Bex A
. Adherence to guideline recommendations for management of clinical T1 renal cancers in the Netherlands: a population-based study. World J Urol. 2016; 34(8):1053-60.
PMC: 4958124.
DOI: 10.1007/s00345-016-1841-3.
View
2.
Noe A, De Bruijn R, Blank C, Horenblas S, Haanen J, Bex A
. Comparison of pre-treatment MSKCC and IMDC prognostic risk models in patients with synchronous metastatic renal cell carcinoma treated in the era of targeted therapy. World J Urol. 2016; 34(8):1067-72.
DOI: 10.1007/s00345-016-1769-7.
View
3.
Kuijpers Y, Meijer R, Jonges G, de Jong J, Bosch J, Horenblas S
. Potentially curable recurrent disease after surgically managed non-metastatic renal cell carcinoma in low-, intermediate- and high-risk patients. World J Urol. 2016; 34(8):1073-9.
DOI: 10.1007/s00345-016-1822-6.
View
4.
Brehmer B, Kauffmann C, Blank C, Heidenreich A, Bex A
. Resection of metastasis and local recurrences of renal cell carcinoma after presurgical targeted therapy: probability of complete local control and outcome. World J Urol. 2016; 34(8):1061-6.
DOI: 10.1007/s00345-016-1865-8.
View
5.
Dabestani S, Thorstenson A, Lindblad P, Harmenberg U, Ljungberg B, Lundstam S
. Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study. World J Urol. 2016; 34(8):1081-6.
DOI: 10.1007/s00345-016-1773-y.
View